pI: 6.5747 |
Length (AA): 195 |
MW (Da): 21487 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 195 | 2awp (A) | 1 | 192 | 52.00 | 0 | 1 | 1.75 | -1.95 |
2 | 195 | 1my6 (A) | 1 | 196 | 47.00 | 0 | 1 | 1.66 | -2.07 |
2 | 195 | 1isa (A) | 1 | 190 | 52.00 | 0 | 1 | 1.78 | -1.96 |
1 | 195 | 3esf (A) | 1 | 195 | 70.00 | 0 | 1 | 1.9722 | -1.82 |
1 | 195 | 2a03 (A) | 1 | 192 | 53.00 | 0 | 1 | 1.761 | -1.49 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126676)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G23310 | Fe superoxide dismutase 3 |
Arabidopsis thaliana | AT4G25100 | superoxide dismutase [Fe] |
Arabidopsis thaliana | AT3G56350 | Iron/manganese superoxide dismutase family protein |
Arabidopsis thaliana | AT5G51100 | Fe superoxide dismutase 2 |
Arabidopsis thaliana | AT3G10920 | Superoxide dismutase [Mn] |
Babesia bovis | BBOV_IV011480 | superoxide dismutase, putative |
Brugia malayi | Bm1_48045 | Superoxide dismutase, mitochondrial precursor, putative |
Candida albicans | CaO19.3340 | likely mitochondrial manganese-containing superoxide dismutase similar to S. cerevisiae SOD2 (YHR008C) |
Candida albicans | CaJ7_0018 | hypothetical protein |
Candida albicans | CaO19.10848 | likely mitochondrial manganese-containing superoxide dismutase similar to S. cerevisiae SOD2 (YHR008C) |
Caenorhabditis elegans | CELE_F10D11.1 | Protein SOD-2 |
Caenorhabditis elegans | CELE_C08A9.1 | Protein SOD-3 |
Cryptosporidium hominis | Chro.50049 | superoxide dismutase |
Cryptosporidium parvum | cgd5_3230 | superoxide dismutase |
Chlamydia trachomatis | CT_294 | superoxide dismutase |
Dictyostelium discoideum | DDB_G0271106 | superoxide dismutase |
Drosophila melanogaster | Dmel_CG8905 | Superoxide dismutase 2 (Mn) |
Escherichia coli | b1656 | superoxide dismutase, Fe |
Escherichia coli | b3908 | superoxide dismutase, Mn |
Echinococcus granulosus | EgrG_000607900 | manganese superoxide dismutase |
Entamoeba histolytica | EHI_159160 | iron-containing superoxide dismutase |
Echinococcus multilocularis | EmuJ_000607900 | manganese superoxide dismutase |
Homo sapiens | ENSG00000112096 | superoxide dismutase 2, mitochondrial |
Leishmania braziliensis | LbrM.32.2010 | iron superoxide dismutase, putative |
Leishmania braziliensis | LbrM.32.2000 | iron superoxide dismutase, putative |
Leishmania braziliensis | LbrM.08.0330 | iron superoxide dismutase |
Leishmania donovani | LdBPK_321920.1 | iron superoxide dismutase, putative |
Leishmania donovani | LdBPK_321910.1 | iron superoxide dismutase, putative |
Leishmania donovani | LdBPK_080300.1 | iron superoxide dismutase A, mitochondrial |
Leishmania infantum | LinJ.32.1920 | iron superoxide dismutase, putative |
Leishmania infantum | LinJ.08.0300 | iron superoxide dismutase |
Leishmania infantum | LinJ.32.1910 | iron superoxide dismutase, putative |
Leishmania major | LmjF.08.0290 | iron superoxide dismutase |
Leishmania major | LmjF.32.1830 | iron superoxide dismutase, putative |
Leishmania major | LmjF.32.1820 | iron superoxide dismutase, putative |
Leishmania mexicana | LmxM.08.0290 | iron superoxide dismutase |
Leishmania mexicana | LmxM.31.1830 | iron superoxide dismutase, putative |
Leishmania mexicana | LmxM.31.1820 | iron superoxide dismutase, putative |
Loa Loa (eye worm) | LOAG_08473 | hypothetical protein |
Mycobacterium leprae | ML0072c | Probable superoxide dismutase SodA |
Mus musculus | ENSMUSG00000006818 | superoxide dismutase 2, mitochondrial |
Mycobacterium tuberculosis | Rv3846 | Superoxide dismutase [FE] SodA |
Mycobacterium ulcerans | MUL_5018 | superoxide dismutase [Fe] SodA |
Neospora caninum | NCLIV_058710 | Superoxide dismutase (EC 1.15.1.1), related |
Neospora caninum | NCLIV_058810 | superoxide dismutase |
Neospora caninum | NCLIV_058830 | Superoxide dismutase (EC 1.15.1.1), related |
Oryza sativa | 4338417 | Os05g0323900 |
Oryza sativa | 4340091 | Os06g0143000 |
Oryza sativa | 4339922 | Os06g0115400 |
Onchocerca volvulus | OVOC1096c | Superoxide dismutase [Mn], mitochondrial homolog |
Onchocerca volvulus | OVOC1096a | Superoxide dismutase [Mn], mitochondrial homolog |
Onchocerca volvulus | OVOC1096b | Superoxide dismutase [Mn], mitochondrial homolog |
Plasmodium berghei | PBANKA_1422700 | superoxide dismutase [Fe], putative |
Plasmodium falciparum | PF3D7_0814900 | superoxide dismutase [Fe] |
Plasmodium knowlesi | PKNH_1425400 | superoxide dismutase [Fe], putative |
Plasmodium vivax | PVX_123030 | superoxide dismutase [Fe], putative |
Plasmodium yoelii | PY05422 | Iron/manganese superoxide dismutases, putative |
Saccharomyces cerevisiae | YHR008C | superoxide dismutase SOD2 |
Schistosoma japonicum | Sjp_0214230 | ko:K04564 superoxide dismutase, Fe-Mn family [EC1.15.1.1A], putative |
Schistosoma mansoni | Smp_056440 | superoxide dismutase [mn] |
Schmidtea mediterranea | mk4.041439.00 | |
Schmidtea mediterranea | mk4.000687.06 | Superoxide dismutase |
Schmidtea mediterranea | mk4.058631.01 | |
Schmidtea mediterranea | mk4.000571.02 | Superoxide dismutase |
Trypanosoma brucei gambiense | Tbg972.11.17840 | iron superoxide dismutase, putative |
Trypanosoma brucei gambiense | Tbg972.5.4710 | iron superoxide dismutase, putative |
Trypanosoma brucei gambiense | Tbg972.11.16860 | iron superoxide dismutase, putative |
Trypanosoma brucei | Tb927.11.15910 | iron superoxide dismutase |
Trypanosoma brucei | Tb927.5.3350 | iron superoxide dismutase A, mitochondrial |
Trypanosoma brucei | Tb927.11.15020 | iron superoxide dismutase |
Trypanosoma congolense | TcIL3000.11.15820 | iron superoxide dismutase |
Trypanosoma congolense | TcIL3000_5_3750 | iron superoxide dismutase A, mitochondrial |
Trypanosoma congolense | TcIL3000.11.15220 | iron superoxide dismutase |
Trypanosoma cruzi | TcCLB.509775.40 | iron superoxide dismutase A, mitochondrial |
Trypanosoma cruzi | TcCLB.508445.20 | iron superoxide dismutase, putative |
Trypanosoma cruzi | TcCLB.507061.30 | iron superoxide dismutase A, mitochondrial |
Trypanosoma cruzi | TcCLB.511019.90 | iron superoxide dismutase, putative |
Trypanosoma cruzi | TcCLB.507039.10 | iron superoxide dismutase, putative |
Trypanosoma cruzi | TcCLB.511715.10 | iron superoxide dismutase, putative |
Toxoplasma gondii | TGME49_316190 | superoxide dismutase SOD3 |
Toxoplasma gondii | TGME49_316330 | superoxide dismutase SOD2 |
Toxoplasma gondii | TGME49_316310 | superoxide dismutase |
Theileria parva | TP01_1156 | iron-dependent superoxide dismutase, putative |
Trichomonas vaginalis | TVAG_079600 | superoxide dismutase [fe], putative |
Trichomonas vaginalis | TVAG_039980 | superoxide dismutase, putative |
Trichomonas vaginalis | TVAG_404200 | superoxide dismutase, putative |
Trichomonas vaginalis | TVAG_161300 | iron superoxide dismutase A, putative |
Trichomonas vaginalis | TVAG_120340 | superoxide dismutase [mn], putative |
Trichomonas vaginalis | TVAG_049140 | superoxide dismutase [fe], putative |
Trichomonas vaginalis | TVAG_337230 | superoxide dismutase [fe], putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0220 | superoxide dismutase, SodA |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.6660 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.6660 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.6660 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.6660 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.01.7550 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.7550 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.7550 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.7550 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.5.3350 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.3350 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.3350 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.3350 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1656 | Escherichia coli | non-essential | goodall |
b3908 | Escherichia coli | non-essential | goodall |
CELE_C08A9.1 | Caenorhabditis elegans | larval arrest | wormbase |
PBANKA_1422700 | Plasmodium berghei | Slow | plasmo |
TGME49_316330 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_316190 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_316310 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_316330 | Toxoplasma gondii | Probably essential | sidik |
TGME49_316190 | Toxoplasma gondii | Probably essential | sidik |
TGME49_316310 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 13663 27775 62726 160641 544760 549785 549786 549788 566370 | |
Annotator: | crowther@u.washington.edu. | Comment: | agents that increase cAMP levels inhibited superoxide dismutase and reduced attachment of promastigotes to mouse macrophages. | References: | 7472855 | |
host cell surface binding (GO:0046812) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 13663 27775 62726 160641 544760 549785 549786 549788 566370 |
Annotator: | crowther@u.washington.edu. | Comment: | agents that increase cAMP levels inhibited superoxide dismutase and reduced attachment of promastigotes to mouse macrophages. | References: | 7472855 | |
growth (GO:0040007) | drug sensitive (PATO:0000529) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania chagasi | 118457 |
Annotator: | crowther@u.washington.edu. | Comment: | heterozygotes with only one copy of the superoxide dismutase gene grew poorly when paraquat was added to increase superoxide levels. | References: | 14500512 | |
viability (PATO:0000169) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania chagasi | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | heterozygotes with only one copy of the superoxide dismutase gene had reduced survival in human macrophages. | References: | 14500512 | |
viability (PATO:0000169) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania chagasi | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | heterozygotes with only one copy of the superoxide dismutase gene had reduced survival in human macrophages. | References: | 14500512 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 107881 557741 |
Annotator: | crowther@u.washington.edu. | Comment: | treatment with phenazine methosulfate, a superoxide dismutase inhibitor, impairs growth of promastigotes and interferes with conversion of amastigotes to promastigotes. | References: | 6328296 | |
cell differentiation (GO:0030154) | disrupted (PATO:0001507) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania amazonensis | 107881 557741 |
Annotator: | crowther@u.washington.edu. | Comment: | treatment with phenazine methosulfate, a superoxide dismutase inhibitor, impairs growth of promastigotes and interferes with conversion of amastigotes to promastigotes. | References: | 6328296 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | 544715 | |
Annotator: | crowther@u.washington.edu. | Comment: | chemical inhibition with cyanide reduces activity of the Cu/Zn-dependent superoxide dismutase found in glycosomes. | References: | 8042972 | |
growth (GO:0040007) | drug insensitive (PATO:0000528) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from over expression (ECO:0000120) | Leishmania chagasi | 118457 205696 525516 542659 542660 549058 549059 |
Annotator: | crowther@u.washington.edu. | Comment: | overexpression of recombinant enzyme confers resistance to superoxide dismutase inhibitors . | References: | 9497044 | |
growth (GO:0040007) | drug insensitive (PATO:0000528) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania chagasi | 118457 205696 525516 542659 542660 549058 549059 |
Annotator: | crowther@u.washington.edu. | Comment: | overexpression of recombinant enzyme confers resistance to superoxide dismutase inhibitors . | References: | 9497044 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from anti-sense experiment (ECO:0000018) | Leishmania donovani | No drug identifiers listed for this gene. | |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to reduced enzyme activity. | References: | 12459037 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from anti-sense experiment (ECO:0000018) | Leishmania tropica | No drug identifiers listed for this gene. | |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to reduced enzyme activity. | References: | 12459037 | |
protein concentration (PATO:0000034) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from anti-sense experiment (ECO:0000018) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to reduced levels of protein. | References: | 12459037 | |
protein concentration (PATO:0000034) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from anti-sense experiment (ECO:0000018) | Leishmania tropica | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to reduced levels of protein. | References: | 12459037 | |
growth (GO:0040007) | drug sensitive (PATO:0000529) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from anti-sense experiment (ECO:0000018) | Leishmania tropica | 18824 205696 |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to increased sensitivity to ROS generators. | References: | 12459037 | |
viability (PATO:0000169) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to reduced growth and survival inside mouse macrophages. | References: | 12459037 | |
viability (PATO:0000169) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from anti-sense experiment (ECO:0000018) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | antisense mRNA inhibition led to reduced growth and survival inside mouse macrophages. | References: | 12459037 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | No drug identifiers listed for this gene. | |
Annotator: | crowther@u.washington.edu. | Comment: | Drug: 865244-53-7 (Triphenyl tin salicylanilide thiosemicarbazone). chemical inhibition with TTST reduced enzyme activity. | References: | 15896700 | |
protein concentration (PATO:0000034) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from specific protein inhibition (ECO:0000020) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | Drug: 865244-53-7 (Triphenyl tin salicylanilide thiosemicarbazone). chemical inhibition with TTST reduced protein expression levels. | References: | 15896700 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | Drug: 865244-53-7 (Triphenyl tin salicylanilide thiosemicarbazone). chemical inhibition with TTST limited growth of promastigotes. | References: | 15896700 | |
viability (PATO:0000169) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | host (GO:0018995) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | Drug: 865244-53-7 (Triphenyl tin salicylanilide thiosemicarbazone). chemical inhibition with TTST limited growth of amastigotes inside hamster macrophages. | References: | 15896700 | |
viability (PATO:0000169) | decreased (PATO:0000468) | single cell organism (CARO:0000064) | amastigote (BTO:0000062) | inferred from bioassay (ECO:0000094) | Leishmania donovani | No drug identifiers listed for this gene. |
Annotator: | crowther@u.washington.edu. | Comment: | Drug: 865244-53-7 (Triphenyl tin salicylanilide thiosemicarbazone). chemical inhibition with TTST limited growth of amastigotes inside hamster macrophages. | References: | 15896700 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 205696 |
Annotator: | crowther@u.washington.edu. | Comment: | enzymatically generated hydrogen peroxide (which may inhibit superoxide dismutase) kills promastigotes. | References: | 7252418 | |
growth (GO:0040007) | decreased time (PATO:0000716) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania tropica | 205696 |
Annotator: | crowther@u.washington.edu. | Comment: | enzymatically generated hydrogen peroxide (which may inhibit superoxide dismutase) kills promastigotes. | References: | 7252418 | |
growth (GO:0040007) | normal (PATO:0000461) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania donovani | 532486 |
Annotator: | crowther@u.washington.edu. | Comment: | enzymatically generated hydrogen superoxide did not kill promastigotes. | References: | 7252418 | |
growth (GO:0040007) | normal (PATO:0000461) | single cell organism (CARO:0000064) | promastigote (BTO:0001124) | inferred from bioassay (ECO:0000094) | Leishmania tropica | 532486 |
Annotator: | crowther@u.washington.edu. | Comment: | enzymatically generated hydrogen superoxide did not kill promastigotes. | References: | 7252418 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania tropica | 205696 | |
Annotator: | crowther@u.washington.edu. | Comment: | treatment with hydrogen peroxide inhibits superoxide dismutase. | References: | 7306201 | |
catalytic activity (GO:0003824) | normal (PATO:0000461) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Leishmania tropica | 544715 | |
Annotator: | crowther@u.washington.edu. | Comment: | treatment with cyanide does not inhibit superoxide dismutase. | References: | 7306201 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Leishmania major | iron superoxide dismutase, putative | Compounds | References |
Plasmodium falciparum | superoxide dismutase [Fe] | Compounds | References |
35 literature references were collected for this gene.